XML 152 R132.htm IDEA: XBRL DOCUMENT
v3.22.2.2

SHARE-BASED PAYMENT - Fair value assumptions of Bonus in performance (Details) | 12 Months Ended
--- | ---
Jun. 30, 2022 USD ($) $ / shares
Bonus Performance Award At Exercise Price 10.5 US Dollar [Member] |
Disclosure of terms and conditions of share-based payment arrangement [line items] |
Stock price at the grant date | $ 5.42
Exercise Price | $ 10.5
Weighted average expected volatility | 24.78%
Dividend rate | 0.00%
Weighted average risk-free interest rate | 1.52%
Weighted average expected life | 2 years 7 months 17 days
Weighted average fair value of stock at measurement date | $ | $ 0.479
Bonus Performance Award At Exercise Price 21.0 US Dollar [Member] |
Disclosure of terms and conditions of share-based payment arrangement [line items] |
Stock price at the grant date | $ 5.42
Exercise Price | $ 21.0
Weighted average expected volatility | 24.78%
Dividend rate | 0.00%
Weighted average risk-free interest rate | 1.52%
Weighted average expected life | 2 years 7 months 17 days
Weighted average fair value of stock at measurement date | $ | $ 0.005

X
- Definition The exercise price of other equity instruments granted. + References No definition available. + Details
Name: | biox_ExercisePriceOtherEquityInstrumentsGranted
Namespace Prefix: | biox_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The percentage of an expected dividend used to calculate the fair value of other equity instruments granted. + References No definition available. + Details
Name: | biox_ExpectedDividendAsPercentageOtherEquityInstrumentsGranted
Namespace Prefix: | biox_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The price of each stock under other equity instruments at the grant date. + References No definition available. + Details
Name: | biox_StockPriceAtGrantDate
Namespace Prefix: | biox_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The weighted average expected life of other equity instruments granted. + References No definition available. + Details
Name: | biox_WeightedAverageExpectedLifeOtherEquityInstrumentsGranted
Namespace Prefix: | biox_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition The weighted average expected volatility of the share price used to calculate the fair value of other equity instruments granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time. + References No definition available. + Details
Name: | biox_WeightedAverageExpectedVolatilityOtherEquityInstrumentsGranted
Namespace Prefix: | biox_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The percentage of weighted average risk-free interest rate used to calculate the fair value of other equity instruments granted. + References No definition available. + Details
Name: | biox_WeightedAverageRiskFreeInterestRateOtherEquityInstrumentsGranted
Namespace Prefix: | biox_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The weighted average fair value at the measurement date of granted equity instruments other than share options. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2022-03-24 -Paragraph 47 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_47_b&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_WeightedAverageFairValueAtMeasurementDateOtherEquityInstrumentsGranted
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=biox_BonusPerformanceAwardAtExercisePrice10.5UsDollarMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=biox_BonusPerformanceAwardAtExercisePrice21.0UsDollarMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |